1. Home
  2. News
  3. Medical Developments International Limited
  4. EU Transition and Trading Update
More Medical Developments International Limited news
Medical Developments International LimitedASX: MVP

EU Transition and Trading Update

Dec 3, 2020 at 5:48 AM EST · Issued by Medical Developments International Limited

Filed with ASX · Dec 3, 2020 at 5:48 AM EST · 3 pages · English

On 6ix: 6ix.com/news/eu-transition-and-trading-update

Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19↗

Medical Developments International Limited on 6ix

Story so far

  • Trading and market updateOct 30, 2018
  • Trading UpdateMay 14, 2018

Earlier from Medical Developments International

  • MVP and MundiPharma cease Australian licensing agreementOct 30, 2020
  • Chairmans and CEOs Address to ShareholdersOct 27, 2020
  • Appointment of CEO - Brent MacGregorOct 14, 2020
  • Appointment of Non-Executive Director - Gordon NaylorOct 14, 2020
  • Medical Developments to take control of EU marketsAug 18, 2020

Later from Medical Developments International

  • MVP completes $25m placementDec 13, 2020
  • MVP Capital Raising PresentationDec 14, 2020
  • Share Purchase PlanDec 17, 2020
  • Results of SPPJan 21, 2021
  • FY21 Half Year Report and AccountsFeb 25, 2021
All Medical Developments International news releases↗

Follow Medical Developments International into a list and get an email when it puts out news.

Follow Medical Developments International
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer